TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study

DOI: 10.1097/PR9.0000000000000576

Keywords: Capsaicin-induced flare, JNJ-39439335, Heat pain detection, Mavatrep, Pharmacokinetics, Pharmacodynamics, TRPV1 receptor antagonist, Single ascending dose

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text